XENODERMAL GRAFTS SATURATED WITH SILVER NANOPARTICLES IN PREPARATION FOR PLASTIC CLOSURE OF POSTOPERATIVE WOUNDS IN PATIENTS WITH NECROTIZING FASCIITIS
Abstract
Introduction. Necrotizing fasciitis (NF) is a severe infection associated with substantial tissue loss and a high risk of wound surface contamination. Standard xenodermal implants used for temporary coverage of postoperative defects frequently experience recurrent bacterial colonization.
Objective was to evaluate the effectiveness of lyophilized xenodermal implants saturated with silver nanoparticles in improving the preparation of postoperative wounds for autografting in patients with NF.
Materials and Methods. The study involved 20 patients with wounds following NF debridement. Patients were divided into two groups: the experimental group received lyophilized xenodermal implants saturated with silver nanoparticles, while the control group received standard xenodermal implants. Evaluations included granulation tissue formation speed suitable for autografting, incidence of secondary infections, and xenodermal implant adhesion duration.
Results. The mean time for granulation tissue formation suitable for grafting in the experimental group was 9.2 ± 0.7 days compared to 14.5 ± 1.1 days in the control group (p<0.05). No secondary infections occurred in the experimental group, whereas the control group had 3 cases. The adhesion duration of xenodermal implants was significantly longer in the experimental group (4.5±0.4 days versus 2.8±0.25 days, p<0.05).
Conclusions. Using xenodermal implants saturated with silver nanoparticles facilitates faster granulation tissue formation, reduces bacterial complication risk, and enhances preparation outcomes for postoperative wound closure.
Downloads
References
Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014 Jan;101(1):e119-25. https://doi.org/10.1002/bjs.9371. Epub 2013 Nov 29. PMID: 24338771.
Xu R, Fang T, Cai W. Case report: A rare case of simultaneous necrotizing fasciitis of the breast and forearm. Front Med (Lausanne). 2024 Jun 14;11:1413593. https://doi.org/10.3389/fmed.2024.1413593. PMID: 38947243; PMCID: PMC11211525.
Allaw F, Wehbe S, Kanj SS. Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment. Curr Opin Infect Dis. 2024 Apr 1;37(2):105-111. https://doi.org/10.1097/QCO.0000000000000988. Epub 2023 Nov 30. PMID: 38037890.
Khimich SD , Stoianovskyi IV, Chemerys OM. Problems of terminology and clinical coding of necrotizing fasciitis. Paediatric Surgery (Ukraine). 2022. 1(74): 14-19; https://doi.org/10.15574/PS.2022.74.14
Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2018 Mar 8;378(10):971. https://doi.org/10.1056/NEJMc1800049. PMID: 29514033.
Himakalasa W, Orrapin S, Wongthanee A, Kulprachakarn K. A randomized controlled trial on the outcome in comparing an alginate silver dressing with a conventional treatment of a necrotizing fasciitis wound. Int J Low Extrem Wounds. 2017;16(2):108–113. https://doi.org/10.1177/1534734617701051.
Jing G, Hu C, Fang K, Li Y, Wang L. How Nanoparticles Help in Combating Chronic Wound Biofilms Infection? Int J Nanomedicine. 2024 Nov 15;19:11883-11921. https://doi.org/10.2147/IJN.S484473. PMID: 39563901; PMCID: PMC11575445.
Meekul J, Chotirosniramit A, Himakalasa W, Orrapin S, Wongthanee A, Pongtam O, Kulprachakarn K, Rerkasem K. A Randomized Controlled Trial on the Outcome in Comparing an Alginate Silver Dressing With a Conventional Treatment of a Necrotizing Fasciitis Wound. Int J Low Extrem Wounds. 2017 Jun;16(2):108-113. https://doi.org/10.1177/1534734617701051. Epub 2017 Apr 17. PMID: 28682725.
Rybka M, Mazurek Ł, Konop M. Beneficial effect of wound dressings containing silver and silver nanoparticles in wound healing—From experimental studies to clinical practice. Life. 2023;13(69). https://doi.org/10.3390/life13010069.
Savchyn VS, Lukavetskyi OV, Huda NV, Stoianovskyi IV, Chemerys OM, Tuziuk NV. Method for treating wounds using lyophilized xenodermotransplants saturated with silver nanoparticles. Ukraine patent UA 111557. 2015 Nov 10. Ukrainian. Application No.: a201504337; Filed 2015 May 05; Published in Bulletin No. 21. International Classification: A61B 17/00.
Singh M, Thakur V, Kumar V, et al. Silver nanoparticles and its mechanistic insight for chronic wound healing: Review on recent progress. Molecules. 2022;27(5587). https://doi.org/10.3390/molecules27175587.
Tuzyuk NV, Pokryshko OV. Microbiological substantiation of the use of xenografts saturated with silver nanocrystals for the treatment of burn wounds. Shpytalna Khirurhiia. 2022;(1):12–18. https://doi.org/10.11603/2414-4533.2022.1.12912.
Abu-Baker A, Tigăran AE, Peligrad T, et al. Exploring an innovative approach: Integrating negative-pressure wound therapy with silver nanoparticle dressings in skin graft procedures. J Pers Med. 2024;14(206). https://doi.org/10.3390/jpm14020206.
Astaneh ME, Fereydouni N. Silver nanoparticles in 3D printing: A new frontier in wound healing. ACS Omega. 2024;9:41107–41129. https://doi.org/10.1021/acsomega.4c04961.
Dove AS, Dzurny DI, Dees WR, et al. Silver nanoparticles enhance the efficacy of aminoglycosides against antibiotic-resistant bacteria. Front Microbiol. 2023;13:1064095. https://doi.org/10.3389/fmicb.2022.1064095.
Baveloni FG, Meneguin AB, Sábio RM, de Camargo BAF, Trevisan DPV, Duarte JL, et al. Antimicrobial effect of silver nanoparticles as a potential healing treatment for wounds contaminated with Staphylococcus aureus in Wistar rats. J Drug Deliv Sci Technol. 2025;103:106445. https://doi.org/10.1016/j.jddst.2024.106445.
Xu L, Wang YY, Huang J, Chen CY, Wang ZX, Xie H. Silver nanoparticles: Synthesis, medical applications and biosafety. Theranostics. 2020;10(20):8996–9031. https://doi.org/10.7150/thno.45413.
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
